NCT00478322View on ClinicalTrials.gov

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

February 29, 2008

Conditions
Diabetes Mellitus, Type 2Obesity
Interventions
DRUG

Placebo

Matching placebo of 100 mg BID

DRUG

INCB013739

INCB013739 100 mg BID

Trial Locations (3)

10461

The Bronx

78229

San Antonio

91911

Chula Vista

Sponsors

Lead Sponsor

Incyte Corporation
All Listed Sponsors
lead

Incyte Corporation

INDUSTRY